Home/Filings/4/0001193125-25-265866
4//SEC Filing

Sims Andrew John Hugh MacIntyre 4

Accession 0001193125-25-265866

CIK 0001095981other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 8:30 AM ET

Size

5.2 KB

Accession

0001193125-25-265866

Insider Transaction Report

Form 4
Period: 2025-11-04
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-11-04$0.51/sh+20,000$10,20068,138 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.504 to $0.509. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001802687

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 8:30 AM ET
Size
5.2 KB